Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : London Pacific Group - LPGL doubles... -- Ignore unavailable to you. Want to Upgrade?

To: rupert1 who wrote (171)	4/16/1999 5:57:00 AM
From: rupert1	Respond to of 737

ADR REPORT - European ADRs mixed in volatile trade Thursday, April 15, 1999 12:51 PM NEW YORK, April 15 (Reuters) - American Depositary Receipts in European companies were mixed Thursday in volatile trade that reflected the scattered nature of the U.S. market. "Every one's a little confused. There's a lot of volatility," said one trader. At midday, there was a sharp divergence in the U.S. market with blue chip stocks up and technology issues down. Traders said telecommunications stocks were lower mirroring the U.S. rout in technology issues. "Its all sectors, there's little that is stock-specific." the trader said. ADRs in London Pacific Holdings (Nasdaq:LPGLY) fell back a bit after rising sharply two days on a whiff of Internet excitement had lured investors into the ADRs. The ADRs were down 3-7/8 at 28-1/2 after surging in the previous two sessions. A spokeswoman for London Pacific said on Wednesday that the rise seemed to have been sparked by interest in the potential value of holdings in unquoted U.S. Internet companies by its Berkeley International Capital Corp unit. Meanwhile, ADRs in BP Amoco (Nyse:BPA) were up after chief executive John Browne told an annual meeting he planned to increase improvement in underlying performance and accelerate cost savings. Drug ADRs were lower amid profit-taking, with Glaxo Wellcome Plc (Nyse:GLX) down 2-1/16 at 60-9/16 and Smithkline Beecham (Nyse:SBH) down 3-13/16 at 66-1/2.